Home » Authors » James Etheridge

Articles by James Etheridge

Nokad Obtains Its First Functional KOs in Rats

April 11, 2007

By James Etheridge

Nokad Obtains Its First Functional KOs in Rats

April 11, 2007

By James Etheridge

Pfizer Initiates Development Of NicOx Glaucoma Drug Candidate

April 4, 2007

By James Etheridge

MilleGen and LFB Partner On New Generation of MAbs

April 4, 2007

By James Etheridge

Pfizer Initiates Development Of NicOx Glaucoma Drug Candidate

April 4, 2007

By James Etheridge

BioAlliance, Spepharm Partner In Deal To Market Loramyc

March 14, 2007

By James Etheridge

Transgene Reports Net '06 Loss But Expects Busy Year Ahead

March 14, 2007

By James Etheridge

BioAlliance, Spepharm Partner In Deal To Market Loramyc

March 14, 2007

By James Etheridge

Transgene Reports Net '06 Loss But Expects Busy Year Ahead

March 14, 2007

By James Etheridge

Celogos Receives €2.5M For Development of Cell Therapies

March 7, 2007

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...